{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:25:25Z","timestamp":1790767525410,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gofs.2018.10.010","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T10:46:46Z","timestamp":1540810006000},"page":"834-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Contraception et cancer. RPC Contraception CNGOF"],"prefix":"10.1016","volume":"46","author":[{"given":"D.","family":"Pragout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Baffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Raccah-Tebeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rousset-Jablonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2018.10.010_bib0305","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.1983.74","article-title":"Oral contraceptives and breast cancer: final report of an epidemiologic study","volume":"47","author":"Vessey","year":"1983","journal-title":"Br J Cancer"},{"issue":"9017","key":"10.1016\/j.gofs.2018.10.010_bib0310","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297\u00a0women with breast cancer and 100,239\u00a0women without breast cancer from 54\u00a0epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.010_bib0315","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/AOG.0000000000000963","article-title":"Contraceptive practices among female cancer survivors of reproductive age","volume":"126","author":"Dominick","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.010_bib0320","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2013.08.008","article-title":"Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study","volume":"88","author":"Vessey","year":"2013","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.010_bib0325","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 Oral Contraception Study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.010_bib0330","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-10-0747","article-title":"Oral contraceptive use and breast cancer: a prospective study of young women","volume":"19","author":"Hunter","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.010_bib0335","first-page":"1375","article-title":"Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study","volume":"11","author":"Kumle","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7621","key":"10.1016\/j.gofs.2018.10.010_bib0340","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.gofs.2018.10.010_bib0345","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.010_bib0350","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmq022","article-title":"Hormonal contraception and risk of cancer","volume":"16","author":"Cibula","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.010_bib0355","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ijc.11167","article-title":"Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study","volume":"105","author":"Dumeaux","year":"2003","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.010_bib0360","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","article-title":"Use of the levonorgestrel-releasing intrauterine system and breast cancer","volume":"106","author":"Backman","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.010_bib0365","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.contraception.2010.11.009","article-title":"Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer","volume":"83","author":"Dinger","year":"2011","journal-title":"Contraception"},{"issue":"2\u00a0Pt 1","key":"10.1016\/j.gofs.2018.10.010_bib0370","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/AOG.0000000000000356","article-title":"Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.010_bib0375","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.contraception.2003.12.015","article-title":"Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer","volume":"69","author":"Strom","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.010_bib0380","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","article-title":"Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.010_bib0385","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(15)00212-0","article-title":"Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276\u00a0women with endometrial cancer from 36\u00a0epidemiological studies","volume":"16","year":"2015","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.010_bib0390","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/09513590902733733","article-title":"The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option","volume":"25","author":"Gadducci","year":"2009","journal-title":"Gynecol endocrinol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.010_bib0395","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.010_bib0400","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/13697137.2011.579650","article-title":"The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review","volume":"14","author":"Wan","year":"2011","journal-title":"Climacteric"},{"issue":"9609","key":"10.1016\/j.gofs.2018.10.010_bib0405","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45\u00a0epidemiological studies including 23,257\u00a0women with ovarian cancer and 87,303\u00a0controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"9599","key":"10.1016\/j.gofs.2018.10.010_bib0410","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573\u00a0women with cervical cancer and 35,509\u00a0women without cervical cancer from 24\u00a0epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.010_bib0415","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2133.1998.02037.x","article-title":"Cutaneous malignant melanoma in women and the role of oral contraceptives","volume":"138","author":"Gefeller","year":"1998","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.010_bib0420","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjc.6600196","article-title":"A pooled analysis of 10\u00a0case-control studies of melanoma and oral contraceptive use","volume":"86","author":"Karagas","year":"2002","journal-title":"Br J Cancer"},{"issue":"17","key":"10.1016\/j.gofs.2018.10.010_bib0425","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.ejca.2011.04.023","article-title":"Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis","volume":"47","author":"Gandini","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gofs.2018.10.010_bib0430","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.gastro.2004.09.018","article-title":"Environemental factors and risk for hepatocellular carcinoma","volume":"127","author":"YU","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gofs.2018.10.010_bib0435","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2007.03.015","article-title":"Oral contraception and the risk of hepatocellular carcinoma","volume":"47","author":"Maheshwari","year":"2007","journal-title":"J Hepatol"},{"issue":"43","key":"10.1016\/j.gofs.2018.10.010_bib0440","first-page":"1","article-title":"Oral contraceptives use and liver cancer risk. A dose-reponse meta-analysis observational studies","volume":"94","author":"Ning","year":"2015","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.010_bib0445","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/bjc.2015.58","article-title":"Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project","volume":"112","author":"McGlynn","year":"2015","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.010_bib0450","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/humrep\/dev160","article-title":"Linear reduction in thyroid cancer risk by oral contraceptive use: a dose-response meta-analysis of prospective cohort studies","volume":"30","author":"Wu","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2018.10.010_bib0455","doi-asserted-by":"crossref","first-page":"103515","DOI":"10.1155\/2015\/103515","article-title":"Reproductive factors but not hormonal factors associated with thyroid cancer risk: a systematic review and meta-analysis","volume":"2015","author":"Cao","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.gofs.2018.10.010_bib0460","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ije\/dyg064","article-title":"Hormonal factors and risk of lung cancer among women?","volume":"32","author":"Kreuzer","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.gofs.2018.10.010_bib0465","doi-asserted-by":"crossref","first-page":"c927","DOI":"10.1136\/bmj.c927","article-title":"Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners\u2019 Oral Contraception Study","volume":"340","author":"Hannaford","year":"2010","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.010_bib0470","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/bmt.2009.262","article-title":"Safe living after hematopoietic cell transplantation","volume":"44","author":"Yokoe","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.gofs.2018.10.010_bib0475","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/00016340802707473","article-title":"Infection risk and intrauterine devices","volume":"88","author":"Martinez","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.gofs.2018.10.010_bib0480","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.contraception.2005.08.007","article-title":"Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.010_bib0485","first-page":"99","article-title":"Intrauterine contraceptive device failures in renal transplant patients","volume":"26","author":"Zerner","year":"1981","journal-title":"J Reprod Med"},{"key":"10.1016\/j.gofs.2018.10.010_bib0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-94-007-2492-1_3","article-title":"Options for fertility preservation in men and boys with cancer","volume":"732","author":"Stahl","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.gofs.2018.10.010_bib0495","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.010_bib0500","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high-risk of veinous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.010_bib0505","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0041-008X(86)90247-4","article-title":"Cyclophosphamide in the seminal fluid of treated males: transmission to females by mating and effect on pregnancy outcome","volume":"84","author":"Hales","year":"1986","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.010_bib0510","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1056\/NEJM197501022920127","article-title":"Letter: Possible sensitivity to vinblastine in prostatic or seminal fluid","volume":"292","author":"Paladine","year":"1975","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.gofs.2018.10.010_bib0515","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/cncr.25106","article-title":"Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study","volume":"116","author":"Sukumvanich","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.010_bib0520","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fertnstert.2007.05.033","article-title":"Use of the levonorgestrel-releasing intrauterine system in breast cancer patients","volume":"90","author":"Trinh","year":"2008","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.010_bib0525","first-page":"CD007245","article-title":"Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen","author":"Dominick","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.010_bib0530","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1933719113503408","article-title":"Levonorgestrel intrauterine system in adjuvant tamoxifen treatment: balance of breast risks and endometrial benefits--systematic review of literature","volume":"21","author":"Gizzo","year":"2014","journal-title":"Reprod Sci"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.010_bib0535","first-page":"149","article-title":"Contraception after breast cancer: a retrospective review of the practice among French gynecologists in the 2000s","volume":"35","author":"Hamy","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.010_bib0540","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1471-0528.12499","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial","volume":"121","author":"Orbo","year":"2014","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.010_bib0545","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"34","key":"10.1016\/j.gofs.2018.10.010_bib0550","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.18632\/oncotarget.17588","article-title":"Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.010_bib0555","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bulcan.2017.10.032","article-title":"Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer","volume":"105","author":"Rousset-Jablonski","year":"2018","journal-title":"Bull Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.010_bib0560","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijgo.2007.08.023","article-title":"Oral contraceptives and clinical recurrence of human papillomavirus lesions and cervical intraepithelial neoplasia following treatment","volume":"100","author":"Frega","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.010_bib0565","first-page":"201","volume":"16","author":"Pag\u00e8s","year":"2014","journal-title":"Med Ther\/Med de la reproduction, gyn\u00e9cologie et endocrinologie"},{"issue":"26","key":"10.1016\/j.gofs.2018.10.010_bib0570","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40\u00a0years after treatment for Hodgkin's lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"issue":"33","key":"10.1016\/j.gofs.2018.10.010_bib0575","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2018.10.010_bib0580","series-title":"Synth\u00e8se \u2013 Femmes porteuses d\u2019une mutation de BRCA1\u00a0ou BRCA2. D\u00e9tection pr\u00e9coce du cancer du sein et des annexes et strat\u00e9gies de r\u00e9duction du risque, Collection recommandations et r\u00e9f\u00e9rentiels","author":"Institut National du Cancer","year":"2017"},{"issue":"22","key":"10.1016\/j.gofs.2018.10.010_bib0585","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6\u00a0genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.010_bib0590","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","article-title":"Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review","volume":"296","author":"Lindor","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.010_bib0595","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/GRF.0b013e3182185a41","article-title":"Lynch syndrome","volume":"54","author":"Backes","year":"2011","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.010_bib0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2015.6789","article-title":"Female hormonal factors and the risk of endometrial Cancer in Lynch syndrome","volume":"314","author":"Dashti","year":"2015","journal-title":"JAMA"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T14:22:22Z","timestamp":1551190942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918302654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2468718918302654"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.010","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception et cancer. RPC Contraception CNGOF","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}